Not available
Quote | Apricus Biosciences Inc. (NASDAQ:APRI)
Last: | $ |
---|---|
Change Percent: | -2.87% |
Open: | $0.23 |
Close: | $0.22 |
High: | $0.23 |
Low: | $0.2069 |
Volume: | 1,101,864 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Apricus Biosciences Inc. (NASDAQ:APRI)
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
Apricus Biosciences (NASDAQ: APRI ): Q3 GAAP EPS of -$0.12. More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , Read more ...
Message Board Posts | Apricus Biosciences Inc. (NASDAQ:APRI)
Subject | By | Source | When |
---|---|---|---|
one more thing : my other message is | smul | investorshub | 08/31/2022 8:28:07 PM |
invest in seel for another 9 months, be | smul | investorshub | 08/31/2022 8:22:18 PM |
Seelos Therapeutics Receives a Research and Development Grant | harr449 | investorshub | 08/24/2022 4:32:37 PM |
Yep. Nice to see it finally back | Invest83838 | investorshub | 08/18/2022 11:45:21 PM |
still needs to go up for 150%, but | smul | investorshub | 08/18/2022 6:50:45 PM |
Apricus Biosciences Inc. Company Name:
APRI Stock Symbol:
NASDAQ Market:
Apricus Biosciences Inc. Website:
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a bioph...